PCMA submitted this comment letter to the Hawaii Consumer Protection and Health Committee in opposition to SB 3072. PCMA’s concerns include a 15-day notification requirement, reimbursement requirements on approved MAC appeals, pharmacy right to refuse service if paid less than acquisition cost, and disclosure of proprietary information during the appeals process.